⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3356550 | 0.74 | — | — | |
| SCHEMBL5798660 | 0.71 | — | — | |
| Bicarbonate SCHEMBL31738461 | 0.69 | — | — | |
| SCHEMBL4073685 | 0.69 | — | — | |
| Water SCHEMBL8221741 | 0.67 | — | — | |
| SCHEMBL31481251 | 0.65 | MEN1 (0.36) | — | |
| SCHEMBL3262997 | 0.65 | — | — | |
| Oxalic Acid SCHEMBL11567656 | 0.56 | — | — | |
| Benzene SCHEMBL88325 | 0.55 | — | — | |
| SCHEMBL56545 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7332354-B2 | Compounds for chemiluminescense procedures | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2008-02-19 | — | — | US | claimed |
| US-20260015321-A1 | CHEMICAL COMPOUNDS AND USES THEREOF | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED (GB) | 2026-01-15 | — | — | US | disclosed |
| US-12466842-B2 | Substituted pyrido [4,3-d]pyrimidines as KRAS modulators | ALTEROME THERAPEUTICS, INC. (US) | 2025-11-11 | — | — | US | disclosed |
| WO-2025149628-A1 | PIPERIDINE DERIVATIVES AS INHIBITORS OF NICOTINAMIDE N-METHYL TRANSFERASE | ASTRAZENECA AB (SE) | 2025-07-17 | — | — | WO | disclosed |
| EP-4583977-A1 | HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS | Chiesi Farmaceutici S.p.A. (IT) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024175081-A1 | SHP2 INHIBITOR COMPOUND AND USE THEREOF | 深圳真实生物医药科技有限公司 | 2024-08-29 | — | — | WO | disclosed |
| WO-2024125464-A1 | TETRAHYDROISOQUINOLIN-ONE DERIVATIVES, PREPARATION METHODS AND MEDICINAL USES THEREOF | JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) | 2024-06-20 | — | — | WO | disclosed |
| CN-116283916-B | Compound with Axl and c-Met kinase inhibition activity and preparation and application thereof | 中国科学院上海药物研究所 | 2024-06-11 | — | — | CN | disclosed |
| CN-118103369-A | Pyridolactam derivatives, preparation method and application thereof | 浙江海正药业股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2024088351-A1 | COMPOUNDS AND USES THEREOF | SUZHOU ZANRONG PHARMA LIMITED (CN) | 2024-05-02 | — | — | WO | disclosed |
| CN-1933853-A | Drug conjugates | UNIV NEW YORK (US) | 2007-03-21 | — | — | CN | disclosed |
| EP-1713484-A2 | COMPOUNDS AND METHODS OF USE | AMGEN INC. (US) | 2006-10-25 | — | — | EP | disclosed |
| CN-1653054-A | Benzoxazine derivatives as 5-HT 6 modulators and uses thereof | HOFFMANN LA ROCHE (CH) | 2005-08-10 | — | — | CN | disclosed |
| WO-2005070891-A2 | COMPOUNDS AND METHODS OF USE | AMGEN INC (US) | 2005-08-04 | — | — | WO | disclosed |
| US-20040214999-A1 | Novel compounds for chemiluminescense procedures | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2004-10-28 | — | — | US | disclosed |
| WO-2004037829-A1 | NOVEL BENZOXAZOLE OR OXAZOLOPYRIDINE COMPOUNDS, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | LES LABORATOIRES SERVIER (FR) | 2004-05-06 | — | — | WO | disclosed |
| EP-1397678-A1 | LUCIFERIN HYDRAZIDES | Roche Diagnostics GmbH (DE) | 2004-03-17 | — | — | EP | disclosed |
| EP-1397488-A1 | NOVEL COMPOUNDS FOR CHEMILUMINESCENSE PROCEDURES | Roche Diagnostics GmbH (DE) | 2004-03-17 | — | — | EP | disclosed |
| WO-2002099428-A1 | LUCIFERIN HYDRAZIDES | ROCHE DIAGNOSTICS GMBH (DE) | 2002-12-12 | — | — | WO | disclosed |
| WO-2002099097-A1 | NOVEL COMPOUNDS FOR CHEMILUMINESCENSE PROCEDURES | ROCHE DIAGNOSTICS GMBH (DE) | 2002-12-12 | — | — | WO | disclosed |